Evidence map›Paper›PMID 22753727›Full record

ArticleAnticancer research2012

Effects of Zeng Sheng Ping/ACAPHA on malignant brain tumor growth and Notch signaling.

Kah Jing Lim, Kda Rajan, Charles G Eberhart

Abstract read
In one paragraph

Article in Anticancer research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kah Jing LimDepartment of Pathology, Johns Hopkins University School of Medicine, 720 Rutland Ave, Ross Building 558, Baltimore, MD 21205, USA.
Kda Rajan
Charles G Eberhart
Johns Hopkins University · US

Funding

Inhibiting Notch activity and brain tumor progression using Zen Sheng Ping (ZSP)R21AT003893 · NCCIH · JOHNS HOPKINS UNIVERSITY · PI EBERHART, CHARLES G · 2008 to 2009
$451k
NCCIH NIH HHS R21 AT003893PHS HHS R21 ATOO3893
6 · The paper itself

Abstract

BACKGROUND/

aimZeng Sheng Ping (ZSP) is a traditional herbal remedy used to prevent progression and growth of neoplastic lesions. It has been shown to inhibit Notch2 expression in a murine lung cancer model, leading us to investigate its therapeutic potential in Notch-dependent brain tumors. MATERIALS AND

methods3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS), apoptosis, and quantitative real-time polymerase chain reaction (RT-PCR) analyses were performed in glioma and medulloblastoma cell lines, and morphological analyses in DAOY flank xenografts.

resultsZSP inhibited brain tumor growth in vitro, in part, by apoptotic induction. Down-regulation of the Notch2 receptor, the pathway target Hairy/Enhancer of Split homolog 1 (Hes1), and of the stem cell markers Nestin and CD133 was also observed. Reductions in tumor mass and increases in the necrotic fraction of DAOY xenografts, in mice treated with oral ZSP were also observed, but these were not significant.

conclusionZSP can block brain tumor growth and the expression of Notch pathway members and stem cell markers in vitro.

Indexed as

AnimalsBrain NeoplasmsCell Growth ProcessesCell Line, TumorDrugs, Chinese HerbalFemaleGlioblastomaHumansMedulloblastomaMiceMice, NudePhytotherapyRandom AllocationReceptors, NotchSignal TransductionXenograft Model Antitumor AssaysDrugs, Chinese HerbalReceptors, Notch

Identifiers

PMID22753727
PMCPMC3575600
OpenAlexW2142264266

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.